Celularity CELU
NASDAQ CELU
$1.60 +0.22 (+15.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celularity (CELU) Non Operating Investment Income (2019 - 2020)

Updated

Celularity (CELU) reported Non Operating Investment Income of -$4.43 million for FY2020, compared with -$7,871 in FY2019.

Analysis

Celularity (CELU) Non Operating Investment Income (2019 - 2020) Analysis & Trends

  • According to Business Quant data, Non Operating Investment Income came in at -$7,871 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Celularity 46.69 Mn 39.16 Mn 2.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -4.43 Mn
Jun 30, 2020 -471,500.00
Mar 31, 2020 429,890.00
Dec 31, 2019 -195,803.00
Sep 30, 2019 -58,660.00
Jun 30, 2019 246,592.00
API Access

Celularity Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CELU&period=max&api_key=YOUR_API_KEY